Skip to main content Accessibility help
×
Home
Hostname: page-component-5cfd469876-tkzrn Total loading time: 0.369 Render date: 2021-06-25T14:31:53.927Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true }

New Insights on the Genetic Basis for Resistance

Published online by Cambridge University Press:  21 June 2016

Charles W. Stratton
Affiliation:
Vanderbilt University School of Medicine, Nashville, Tennessee

Extract

One of the more important aspects of nosocomial infections is that they often are caused by bacterial strains resistant to many antimicrobial agents. Despite over 50 years in the development and use of a wide variety of antibiotics, bacterial resistance mechanisms have not been defeated and are playing an increasingly important role in the therapy of infections.

The mechanisms of bacterial resistance, moreover, are constantly changing, but our understanding of these resistance mechanisms at a molecular level is rapidly increasing.” Yet importantly, a detailed knowledge and understanding of the genetic basis for bacterial resistance is of great importance for the proper evaluation and control of nosocomial infections caused by resistant pathogens. The purpose of this discussion is to provide insights into the genetic basis for bacterial resistance and to describe some newer mechanisms of bacterial resistance that influence the therapeutic approach to nosocomial infections.

Type
Special Sections
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1989

Access options

Get access to the full version of this content by using one of the access options below.

References

1. Lyon, BR, Skurray, R: Antimicrobial resistance of Staphylococcus aureus. Microbiol Rev 1987; 51:83134.Google ScholarPubMed
2.Speller, DCE: Hospital infection by multi-resistant gram-negative bacilli. J Antimicrob Chemother 1980; 6: 16X170.CrossRefGoogle ScholarPubMed
3.Neu, HC: The emergence of bacterial resistance and irs influence on empiric therapy. Rev Infect Dis 1983; 5(suppl):S9S20.CrossRefGoogle Scholar
4.Neu, HC: Changing mechanisms of bacterial resistance. Am J Med 1984; 77:1123.CrossRefGoogle ScholarPubMed
5.Young, HK: Recent advances in the evolution of drug resistance. J Antimicrob Chemother 3985; 16:679680.CrossRefGoogle Scholar
6.Greenwood, D: Phenotypic resistance to antimicrobial agents. J Antimicrob Chemother 15:653658.CrossRefGoogle Scholar
7.Gunnison, JB, Fraher, MA. Jawetz, E: Persistence of Staphylococcus aureus in penicillin in-vitro. J Gen Microbiol 1963; 34:335349.Google Scholar
8.Greenwood, D, O'Grady, F: Trimodal response of Escherichia coli and Proteus mirabilis to penicillins. Nature 1970; 228:457458.CrossRefGoogle ScholarPubMed
9.Tuomanen, E, Cozens, R. Tosch, W, et at: The rate of killing of Escherichia coli by β-Iactam antibiotics is strictly proportional to the rate of bacterial growth. J Gen Microbiol tY86; 132:12971304.Google Scholar
10.Richmond, MH. Sykes, RB: The β-lactamases of gram-negative bacteria and their possible physiologic role. Adv Microb Physiol 1973; 9:3188.CrossRefGoogle Scholar
11.Sanders, CC. Sanders, WE Jr: Emergence of resistance to cefamandole: Possible role of cefoxitin-inducible β-lactamases. Antimicrob Agents Chum-other 1979; 15:792797.CrossRefGoogle Scholar
12.Sanders, CC, Sanders, WE Jr: Emergence of resistance during therapy with the newer β-lactam antibiotics: Rote of inducible β-lactamases and implications for the future. Rev Infect Dis 1983; 5:639648.CrossRefGoogle Scholar
13.Bush, K, Freudenberger, JS, Sykes, RB: Interaction of aztreonam and related monobactams with β-lactamases from gram-negative bacteria. Antimicrob Agents Chemother 1982; 22:414420.CrossRefGoogle Scholar
14.Parr, TR. Bayer, AS: Mechanisms of aminoglycoside resistance in variants of Pseudomonas aeruginosa isolated during treatment of experimentat endocarditis in rabbits. J Infect Dis 1988; 158: 10031010.CrossRefGoogle ScholarPubMed
15.Bryan, LE: Aminoglycoside resistance, in Bryan, LE (ed): Antimicrobial Drug Resistance, Orlando, Fla, Academic Press, 1984.Google Scholar
16.Bryan, LE, Kwan, S: Roles of ribosomal binding, membrane potential and electron transport in bacterial uptake of streptomycin and gentamicin. Antimkrob Agents Chemother 1983; 23:835845.CrossRefGoogle ScholarPubMed
17.Mawer, SL. Greenwood, D: Specific and non-specific resistance to aminoglycosides in Escherichia coli. J Clin Pathol 1978; 31:1215.CrossRefGoogle ScholarPubMed
18.Mawer, SL, Greenwood, D: Aminoglycoside resistance emerging during therapy. Lancet 1977; 1:749750.CrossRefGoogle ScholarPubMed
19.Sanders, CC, Sanders, WE Jr: Type I β-lactamases of gram-negative bacteria: Interactions with β-lactam antibiotics. J Inject Dis 1986; 154:792800.CrossRefGoogle ScholarPubMed
20.Livermore, DM, Yang, YJ: β-lactamase liability and Inducer power of newer β-lactams in relation to their activity against β-lactamase inducibility mutants of Pseudomonas aeruginosa. J Infect Dis 1987; 155:775782.CrossRefGoogle Scholar
21.Vu, H. Nikaido, H: Role of β-lactam hydrolysis in mechanism of resistance of a β-lactamase-constitutive Enterobacter cloacae strain to expanded spectrum β-lactams. Antimicrob Agents Chemother tY85: 27:393398.CrossRefGoogle Scholar
22.Stratton, CW, Tausk, F: Synergistic resistance mechanisms in Pseudomonas aeruginosa. J Antimicrob Chemother 1987; 19:413410.CrossRefGoogle Scholar
23.Qtinn, JP. Di Vincenzo, CA, Foster, J: Emergence of resistance to ceftazidime during therapy tor Enterobacter cloacae infections. J Infect Dis 1987: 155:942947.Google Scholar
24.Nikaido, H: Role of permeability barriers in resistance to β-lactam antibiotics. Pharmacol Titer 1985; 27:197231.Google ScholarPubMed
25.Hancock, REW: Role of porins in outer membrane permeability. J Bacteriol 1987: 169:929933.CrossRefGoogle Scholar
26.Quinn, JP, Studemeister, AE. DiVincenzo, CA, et al: Resistance to imipenem in Pseudomonas aeruginosa: Clinical experience and biochemical mechanisms. Rev Infect Dis 1988; 10:892898.CrossRefGoogle ScholarPubMed
27.Legakis, NJ, Tzouvelekm, LS, Makris, A, et al: Outer membrane alterations in multiresistant mutants of Pseudomonas aeruginosa selected by ciprofloxacin. Antimicrob Agents Chemother 1989; 33:124127.CrossRefGoogle ScholarPubMed
28.Robillard, NJ. Scarpa, AL: Genetic: and physiological characterization of ciprofloxacin resistance in Pseudomonas aeruginosa PAO. Antimicrob Agents Chemother 1988; 32:535539.CrossRefGoogle ScholarPubMed
29.Neu, HC: Bacterial resistance to fluoroquinolones. Rev Infect Dis 1988: 10(suppl 1):S27S63.CrossRefGoogle Scholar
30.Stratton, CW, Franke, JJ, Weeks, LS. et al: Comparison of the bactericidal activity of ciprofloxacin alone and in combination with selected anti-pseudomonal β-lactam agents against clinical isolates of Pseudomonas aeruginosa. Diagn Microbiol Infect Dis 1989; 11:4152.CrossRefGoogle Scholar
31.Sanders, CC, Sanders, WF Jr., Goering, RV. et al: Selection of multiple-antibiotic resistance by quinolones, β-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes. Antimicrob Agents Chemother 1984; 26:797801.CrossRefGoogle Scholar
32.Lupski, JR: Molecular mechanisms for transposition of drug-resistance genes and other movable genetic elements. Rev Infect Dis 1987; 9:357368.CrossRefGoogle ScholarPubMed
33.Engel, HWB, Soedirman, N. Rost, JA, et al: Transterability of macrolide lincomycin and Streptogramiu resistances between group A. B and D streptococci, Streptococcus pneumoniae and Staphylococcus aureus. J Bacteriol 1980; 142:407413.Google Scholar
34.Guiney, DG Jr: Promiscuous transfer of drug resistance in gram-negative bacteria. J Infect Dis, 1984; 149:320328.CrossRefGoogle ScholarPubMed
35.Wiedemann, B, Meyer, JF, Nies, BA, et al: Transposable multiresistance. J Antimicrob Chemother 1985; 16:416417.CrossRefGoogle ScholarPubMed
36.Shaberg, DR. Rubens, CE, Alford, RH, et al: Evolution of antimicrobial resistance and nosocomial infection. Am J Med 1981; 70:445448.CrossRefGoogle Scholar
37.Kliebe, C, Nies, BA, Meyer, JE, et al: Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob Agents Chemother 1985; 28:302307.CrossRefGoogle Scholar
38.Sougakoff, W, Goussard, S, Gerbaud, G, et al: Plasmid-niediated resistance to third-generation cephalosporins caused by point mutations in TEM-type penicillinase genes. Rev Infect Dis 1988:10:879884.CrossRefGoogle Scholar
39.Sirot, D, Sirot, J, Labia, R. et al: Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: Identification of CTX-1, a novel β-lactamase. J Antimicrob Chemother 1987; 20:323334.CrossRefGoogle ScholarPubMed
40.Petit, A. Sirot, DL, Chanal, M, et al: Novel plasmid-mediated β-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporins. Antimicrob Agents Chemother 1988; 32:626630.CrossRefGoogle Scholar
41.Lacey, RW: Evolution of microorganisms and antibiotic resistance. Lancet 1984; ii: 10221025.CrossRefGoogle Scholar
42.Hawkey, PM: The molecular evolution of antibiotic resistance genes in gram-negative bacteria. J Antimicrob Chemother 1986; 18:147151.CrossRefGoogle Scholar
43.Datta, N. Kontomichalou, P: Penicillinase synthesis controlled by infectious R-factors in Enterobactenaceae. Nature (London) 1965; 208:239241.CrossRefGoogle Scholar
44.Matthew, M: Plasmid-mediated β-lactamases of gram-negative bacteria: Properties and distribution. J Antimicrob Chemother 1979; 5:349358.CrossRefGoogle ScholarPubMed
45.Hedges, RW. Jacob, AE: Transposition of ampieillin resistance from RP4 to other replicons. Mol Gen Genet 1974: 132:3140.CrossRefGoogle Scholar
46.Archer, GL. Johnston, JL: Self-transmissible plasmids in staphylococci that encode resistance to aminoglycosides. Antimicrob Agents Chemother 1983; 24:7077.CrossRefGoogle Scholar
47.Ikeda, DP. Barry, AL. Anderson, SG: Emergence of Streptococcus faecalis isolates with high-level resistance to multiple aminocyclitol aminoglycosides. Diag Microbiol Infect Dis 1984; 2:171177.CrossRefGoogle ScholarPubMed
48.Murray, BE, Mederski-Samoraj, BD: Transferable β-lactamase: A new mechanism for in-vitro penicillin resistance in Streptococcus faecalis. J Clin Invest 1983; 72:11681171.CrossRefGoogle ScholarPubMed
49.Williamson, R, Al-Obeid, S, Shlaes, JH. et al: Inducible resistance to Vancomycin in Enterococcus faecium D366. J Infect Dis 1989; 159: 10951104.CrossRefGoogle ScholarPubMed
50.Uttley, AHC, Collins, CH, Naidodo, J, et al: Vancomvcin-resistaiit enterococci. Lancet 1988; i:5758.CrossRefGoogle Scholar
1
Cited by

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

New Insights on the Genetic Basis for Resistance
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

New Insights on the Genetic Basis for Resistance
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

New Insights on the Genetic Basis for Resistance
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *